loder

Global Global Influenza Market

Global Influenza Market - By Vaccine Type: Trivalent Vaccines, Quadrivalent Vaccines. By Product: Injectable Vaccines, Nasal Sprays. By Application: Pediatric, Adult, Geriatric. By Distribution Channel: Hospitals, Retail Pharmacies, Clinics, Online Pharmacies. By End-user: Healthcare Providers, Government Programs, Private Consumers. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
Report Code
CVMI2501027
Published
March 3, 2025
Last Updated
March 3, 2025
Coverage
Healthcare • Healthcare
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
vs. prior year
CAGR
Forecast window:
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.
nan
nan
nan

Key Players

  • Sanofi Pasteur
  • GlaxoSmithKline plc
  • Seqirus (CSL Limited)
  • AstraZeneca plc
  • Mylan N.V.
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.
Global Global Influenza Market Report

Global Global Influenza Market Report


    1. Global Global Influenza Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Global Influenza Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Global Influenza Market Research Report - Preface
    1. 2.1 Global Global Influenza Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Vaccine Type
      2. 2.1.2 By Product
      3. 2.1.3 By Application
      4. 2.1.4 By Distribution Channel
      5. 2.1.5 By End-user
      6. 2.1.6 By Region
    3. Global Global Influenza Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, By Country
    3. 3.3. Opportunities – By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, By Country
    4. 3.4. Trends – By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Global Influenza Market Research Report – DROTs Impact Analysis
    4. Global Global Influenza Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Global Influenza Market, By Vaccine Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Trivalent Vaccines
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Quadrivalent Vaccines
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Global Influenza Market, By Product, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Injectable Vaccines
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Nasal Sprays
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Global Influenza Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Pediatric
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Adult
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Geriatric
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Global Influenza Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Hospitals
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Retail Pharmacies
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Clinics
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Online Pharmacies
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    9. Global Global Influenza Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 Healthcare Providers
      1. 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 9.2 Government Programs
      1. 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 9.3 Private Consumers.
      1. 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    10. Global Global Influenza Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 North America
      1. 10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 10.2 Europe
      1. 10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 10.3 Asia-Pacific
      1. 10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 10.4 Latin America
      1. 10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 10.5 Middle East & Africa
      1. 10.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 10.6 Global Global Influenza Market - Opportunity Analysis Index, By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, and Region, 2024 - 2031
    11. North America Global Global Influenza Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      11.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Trivalent Vaccines
      2. 11.1.2 Quadrivalent Vaccines
      11.2 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Injectable Vaccines
      2. 11.2.2 Nasal Sprays
      11.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Pediatric
      2. 11.3.2 Adult
      3. 11.3.3 Geriatric
      11.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Hospitals
      2. 11.4.2 Retail Pharmacies
      3. 11.4.3 Clinics
      4. 11.4.4 Online Pharmacies
      11.5 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.5.1 Healthcare Providers
      2. 11.5.2 Government Programs
      3. 11.5.3 Private Consumers.
      11.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.6.1 United States
      2. 11.6.2 Canada
      11.7 North America Global Global Influenza Market – Opportunity Analysis Index, By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, and Country, 2024 - 2031
      11.8 Regional Trends Analysis
      11.9 North America Global Global Influenza Market Research Report - Company Profiles
      1. 11.9.1 Company 1 (United States)
      2. 11.9.2 Company 2 (Canada)
      3. 11.9.3 Company 3 (Canada)
    12. Europe Global Global Influenza Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      12.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Trivalent Vaccines
      2. 12.1.2 Quadrivalent Vaccines
      12.2 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Injectable Vaccines
      2. 12.2.2 Nasal Sprays
      12.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Pediatric
      2. 12.3.2 Adult
      3. 12.3.3 Geriatric
      12.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Hospitals
      2. 12.4.2 Retail Pharmacies
      3. 12.4.3 Clinics
      4. 12.4.4 Online Pharmacies
      12.5 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.5.1 Healthcare Providers
      2. 12.5.2 Government Programs
      3. 12.5.3 Private Consumers.
      12.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.6.1 Germany
      2. 12.6.2 United Kingdom
      3. 12.6.3 France
      4. 12.6.4 Spain
      5. 12.6.5 Italy
      6. 12.6.6 Russia
      7. 12.6.7 Netherlands
      8. 12.6.8 Poland
      9. 12.6.9 Rest of Europe
      12.7 Europe Global Global Influenza Market – Opportunity Analysis Index, By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, and Country, 2024 - 2031
      12.8 Regional Trends Analysis
      12.9 Europe Global Global Influenza Market Research Report - Company Profiles
      1. 12.9.1 Company 1 (Germany)
      2. 12.9.2 Company 2 (United Kingdom)
      3. 12.9.3 Company 3 (United Kingdom)
    13. Asia-Pacific Global Global Influenza Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      13.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Trivalent Vaccines
      2. 13.1.2 Quadrivalent Vaccines
      13.2 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Injectable Vaccines
      2. 13.2.2 Nasal Sprays
      13.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Pediatric
      2. 13.3.2 Adult
      3. 13.3.3 Geriatric
      13.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Hospitals
      2. 13.4.2 Retail Pharmacies
      3. 13.4.3 Clinics
      4. 13.4.4 Online Pharmacies
      13.5 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.5.1 Healthcare Providers
      2. 13.5.2 Government Programs
      3. 13.5.3 Private Consumers.
      13.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.6.1 China
      2. 13.6.2 Japan
      3. 13.6.3 India
      4. 13.6.4 South Korea
      5. 13.6.5 Australia & NZ
      6. 13.6.6 ASEAN
      7. 13.6.7 Rest of Asia-Pacific
      13.7 Asia-Pacific Global Global Influenza Market – Opportunity Analysis Index, By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, and Country, 2024 - 2031
      13.8 Regional Trends Analysis
      13.9 Asia-Pacific Global Global Influenza Market Research Report - Company Profiles
      1. 13.9.1 Company 1 (China)
      2. 13.9.2 Company 2 (Japan)
      3. 13.9.3 Company 3 (Japan)
    14. Latin America Global Global Influenza Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      14.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.1.1 Trivalent Vaccines
      2. 14.1.2 Quadrivalent Vaccines
      14.2 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.2.1 Injectable Vaccines
      2. 14.2.2 Nasal Sprays
      14.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.3.1 Pediatric
      2. 14.3.2 Adult
      3. 14.3.3 Geriatric
      14.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.4.1 Hospitals
      2. 14.4.2 Retail Pharmacies
      3. 14.4.3 Clinics
      4. 14.4.4 Online Pharmacies
      14.5 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.5.1 Healthcare Providers
      2. 14.5.2 Government Programs
      3. 14.5.3 Private Consumers.
      14.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.6.1 Brazil
      2. 14.6.2 Mexico
      3. 14.6.3 Argentina
      4. 14.6.4 Peru
      5. 14.6.5 Colombia
      6. 14.6.6 Rest of Latin America
      14.7 Latin America Global Global Influenza Market – Opportunity Analysis Index, By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, and Country, 2024 - 2031
      14.8 Regional Trends Analysis
      14.9 Latin America Global Global Influenza Market Research Report - Company Profiles
      1. 14.9.1 Company 1 (Brazil)
      2. 14.9.2 Company 2 (Mexico)
      3. 14.9.3 Company 3 (Mexico)
    15. Middle East & Africa Global Global Influenza Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      15.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.1.1 Trivalent Vaccines
      2. 15.1.2 Quadrivalent Vaccines
      15.2 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.2.1 Injectable Vaccines
      2. 15.2.2 Nasal Sprays
      15.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.3.1 Pediatric
      2. 15.3.2 Adult
      3. 15.3.3 Geriatric
      15.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.4.1 Hospitals
      2. 15.4.2 Retail Pharmacies
      3. 15.4.3 Clinics
      4. 15.4.4 Online Pharmacies
      15.5 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.5.1 Healthcare Providers
      2. 15.5.2 Government Programs
      3. 15.5.3 Private Consumers.
      15.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.6.1 Saudi Arabia
      2. 15.6.2 UAE
      3. 15.6.3 South Africa
      4. 15.6.4 Egypt
      5. 15.6.5 Israel
      6. 15.6.6 Rest of Middle East and Africa
      15.7 Middle East & Africa Global Global Influenza Market – Opportunity Analysis Index, By Vaccine Type, By Product, By Application, By Distribution Channel, By End-user, and Country, 2024 - 2031
      15.8 Regional Trends Analysis
      15.9 Middle East & Africa Global Global Influenza Market Research Report - Company Profiles
      1. 15.9.1 Company 1 (Saudi Arabia)
      2. 15.9.2 Company 2 (UAE)
      3. 15.9.3 Company 3 (UAE)
    16. Competition Landscape
      16.1 Strategic Dashboard of Top Market Players
      16.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 16.2.1 Sanofi Pasteur
      2. 16.2.2 GlaxoSmithKline plc
      3. 16.2.3 Seqirus (CSL Limited)
      4. 16.2.4 AstraZeneca plc
      5. 16.2.5 Mylan N.V.
    17. Data Collection Method and Research Approach
    18. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
New chat message received
×

Need help?

Chat with our team in a minute.